Raymond Pratt
Chief Tech/Sci/R&D Officer at SAVARA INC.
Net worth: 796 800 $ as of 2024-03-30
Profile
Raymond D.
Pratt is an Independent Director at XORTX Therapeutics, Inc. and the Chief Medical Officer at Savara, Inc. He previously worked as the Assistant Chief & Director-Dialysis Services at Walter Reed Army Medical Center, Senior Director-Clinical Research & Development at Eisai Medical Research, Inc., Vice President-Strategic Drug Development at Quintiles Transnational Corp., Chief Development Officer at Rockwell Medical, Inc., Vice President-Research & Development at Shire Plc and Shire Pharmaceutical Development, Inc., and Assistant Professor at Weill Cornell Medical College and The Johns Hopkins University School of Medicine.
Pratt holds a doctorate degree from the University of Illinois College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SAVARA, INC.
0.12% | 2023-12-13 | 160,000 ( 0.12% ) | 796 800 $ | 2024-03-30 |
XORTX THERAPEUTICS, INC.
-.--% | 2024-03-03 | 0 ( -.--% ) | - $ | 2024-03-30 |
Raymond Pratt active positions
| Companies | Position | Start |
|---|---|---|
| XORTX THERAPEUTICS INC. | Director/Board Member | 2021-12-19 |
| SAVARA INC. | Chief Tech/Sci/R&D Officer | 2022-11-09 |
Former positions of Raymond Pratt
| Companies | Position | End |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Chief Tech/Sci/R&D Officer | 2019-11-19 |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | 2011-12-31 |
| SHIRE | Chief Operating Officer | 2009-12-31 |
Shire Pharmaceutical Development, Inc.
 Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Chief Tech/Sci/R&D Officer | 2009-12-31 |
| Eisai Medical Research, Inc. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Training of Raymond Pratt
| University of Illinois College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| SAVARA INC. | Health Technology |
| XORTX THERAPEUTICS INC. | Health Technology |
| Private companies | 5 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Walter Reed Army Medical Center | |
| Eisai Medical Research, Inc. | |
Shire Pharmaceutical Development, Inc.
Shire Pharmaceutical Development, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Development, Inc. engages in research and development of pharmaceutical drugs. It develops drugs for the treatment of metachromatic leukodystrophy, hereditary angioedema, hunter syndrome, and gaucher diseases. The company was founded in 2000 and is headquartered in Rockville. MD. | Health Technology |
- Stock Market
- Insiders
- Raymond Pratt
